The Trump administration has approved eight drugmakers’ rebate plans for a controversial 340B drug discount pilot program that kicks off January 1.
Related Posts
KFF Tracker: America First MOU Bilateral Global Health Agreements
Editorial Note: Originally published on January 13, 2026, this resource will be updated as needed, most recently on February 3, 2026, to reflect additional developments. […]
Hello Patient Secures $22.5M for Conversational AI Solution
Hello Patient, a conversational AI company, has raised $22.5 million in Series A funding, which it will use to scale to more healthcare organizations and […]
Strategies for Sustainable and Scalable Healthcare Practices
How can healthcare leaders address burnout while driving operational efficiency and scalable growth? In this week’s podcast, Stewart Gandolf sits down with Edisa Shirley, Chief […]